These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 6866310
1. [Dysmyelopoietic syndrome 7 years after melphalan treatment of multiple myeloma. Clinical case]. Scolozzi R, Boccafogli A. Minerva Med; 1983 Jul 14; 74(28-29):1783-5. PubMed ID: 6866310 [Abstract] [Full Text] [Related]
3. Comparison of melphalan and prednisone with vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of multiple myeloma: results of Eastern Cooperative Oncology Group Study E2479. Oken MM, Harrington DP, Abramson N, Kyle RA, Knospe W, Glick JH. Cancer; 1997 Apr 15; 79(8):1561-7. PubMed ID: 9118039 [Abstract] [Full Text] [Related]
4. Melphalan-prednisone versus alternating combination VAD/MP or VND/MP as primary therapy for multiple myeloma: final analysis of a randomized clinical study. Cavo M, Benni M, Ronconi S, Fiacchini M, Gozzetti A, Zamagni E, Cellini C, Tosi P, Baccarani M, Tura S, Writing Committee of the "Bologna 90" Clinical Trial. Haematologica; 2002 Sep 15; 87(9):934-42. PubMed ID: 12217805 [Abstract] [Full Text] [Related]
6. Prognostic factors and survival in multiple myeloma. Analysis of 91 cases treated by melphalan and prednisone. Gobbi M, Cavo M, Savelli G, Baccarani M, Tura S. Haematologica; 1980 Aug 15; 65(4):437-45. PubMed ID: 6774915 [No Abstract] [Full Text] [Related]
8. [Intermittent low dose melphalan and prednisone in multiple myeloma]. Yalon M, Levo Y, Many A, Ramot B. Harefuah; 1977 Apr 01; 92(7):296-8. PubMed ID: 863310 [No Abstract] [Full Text] [Related]
12. [Case of IgG-K myeloma successfully treated with melphalan but terminating in acute myelogenous leukemia 2 years and 8 months later]. Saitoh A, Tsushima T, Narita K, Fujiwara S, Kawamura S, Chiba Y, Yoshida Y. Rinsho Ketsueki; 1982 Jun 01; 23(6):862-9. PubMed ID: 6960198 [No Abstract] [Full Text] [Related]
14. [Therapy results and clinical course in 91 cases of multiple myeloma with regard to their clinical staging (author's transl)]. Rubio Felix D, Giraldo MP, Raichs A, García Zueco JC, Mur P, Faura MV, Ruíz-Marcuello E, Piñan MA. Sangre (Barc); 1980 Jun 01; 25(1):25-34. PubMed ID: 7384962 [No Abstract] [Full Text] [Related]
15. [Cytomorphological, immunochemical and therapeutic aspects of multiple myeloma]. Maroncelli P, Casalino C. Minerva Med; 1973 Feb 17; 64(8):337-57. PubMed ID: 4120544 [No Abstract] [Full Text] [Related]
19. [Erythroleukemia in multiple myeloma. A case report]. Streuli R, Voellmy W. Schweiz Med Wochenschr; 1987 Feb 21; 117(8):286-91. PubMed ID: 3470922 [Abstract] [Full Text] [Related]